4//SEC Filing
SPIEGELMAN DANIEL K 4
Accession 0000950170-25-080456
CIK 0001994702other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 6:35 PM ET
Size
7.2 KB
Accession
0000950170-25-080456
Insider Transaction Report
Form 4
SPIEGELMAN DANIEL K
Director
Transactions
- Award
Common Stock
2025-05-29+16,634→ 16,634 total - Award
Stock Option (right to buy)
2025-05-29+65,351→ 65,351 totalExercise: $2.63Exp: 2035-05-29→ Common Stock (65,351 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
- [F2]All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
Documents
Issuer
Kyverna Therapeutics, Inc.
CIK 0001994702
Entity typeother
Related Parties
1- filerCIK 0001238403
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 6:35 PM ET
- Size
- 7.2 KB